Lana Medical Co.
9587.SRSAUHealthcare● Active
$2.79
$-0.01(-0.36%)
Market Cap$150660000
P/E Ratio—
52W High$3.934
52W Low$2.07
Lana Medical Co. (9587.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 9587.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $2.70M | $13.62M | $3.01M | $5.49M | $6.59M |
| Depreciation & Amort. | $5.73M | $3.51M | $0.00M | $1.53M | $1.08M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | ($14.23M) | ($12.20M) | ($8.68M) | ($3.91M) | ($13.97M) |
| Net Cash from Operations | ($8.97M) | $0.39M | $1.43M | $5.45M | ($4.95M) |
| Investing Activities | |||||
| Capital Expenditure | ($4.73M) | ($4.12M) | $0.00M | ($5.10M) | ($7.22M) |
| Purchases of Investments | ($0.02M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($3.52M) | ($14.66M) | ($4.05M) | ($5.10M) | ($7.10M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $13.04M | $3.13M | $1.21M | ($0.19M) | ($0.11M) |
| Net Cash from Financing | $10.67M | $1.86M | $18.07M | ($0.57M) | $11.98M |
| Free Cash Flow | |||||
| Free Cash Flow | ($13.70M) | ($3.73M) | $1.43M | $0.36M | ($12.17M) |
| FCF Margin %(computed) | -14.85% | -4.43% | 2.94% | 0.87% | -38.06% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · M
Explore more Lana Medical Co. data
About Lana Medical Co. (9587.SR) Cash Flow Statement
Lana Medical Co. generated operating cash flow of ($0.01B) and free cash flow of ($0.01B) for 2025 — a FCF margin of -14.85%. Capital expenditure was ($0.00B).
Frequently asked questions
9587.SR · 4 questionsLana Medical Co. generated free cash flow of ($0.01B) for 2025, down 267.7% year-over-year.
9587.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15